Skip to main content
SleepCited

Glycine para Insomnio

A Evidencia Múltiples ensayos clínicos de gran tamaño muestran de forma consistente beneficios significativos.

Basado en 36 estudios (2 meta-analyses, 6 RCTs) con 484,248 participantes en total. 22/36 estudios muestran efectos positivos.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dglycine\u0026condition\u003Dinsomnia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Conclusión

Glycine is supported by strong evidence as a supplement that may help improve overall sleep quality, with benefits seen in multiple well-designed clinical trials.

  • 22 out of 36 studies show positive effects, with 6 RCTs and 2 meta-analyses
  • Glycine may promote sleep by lowering core body temperature, a natural sleep trigger
  • A 2024 RCT showed collagen peptides (glycine-rich) reduced sleep fragmentation
  • Large evidence base of over 484,000 participants across all study types

Key Study Findings

basic science
Lactobacillus reuteri E9 Regulates Sleep Disorders Through Its Metabolite GABA.
Dose: Lactobacillus reuteri E9 (dose not specified) vs: Placebo Efecto: None < 0.05
systematic review n=451 Double-blind
Effectiveness of Homoeopathic Treatments for Sleep Disorders in Children and Adolescents: A Systematic Review According …
Dose: various homoeopathic remedies (complex homoeopathy, Melissa officinalis 12C, individualised homoeopa vs: Placebo Efecto: bruxism: ΔVAS -2.36 vs -1.72; enuresis: median -2.4 nights/week 0.05 (bruxism); < 0.04 (enures
basic science
Time-specific study on the efficacy of stems and leaves of Arachis hypogaea L. targeting glycine/serine …
Dose: Arachis hypogaea L. stems and leaves extract vs: Placebo Efecto: None None
randomized controlled trial n=13 1 weeks Double-blind
Collagen peptide supplementation before bedtime reduces sleep fragmentation and improves cognitive function in physically active …
Dose: 15 g/day collagen peptides (glycine-rich) consumed 1 hour before bedtime for 7 nights vs: Placebo Efecto: None 0.028
animal experimental 3 weeks
Effects of BXSMD on ESR1 and ESR2 expression in CSD female mice.
Dose: None vs: Placebo Efecto: None None

Key Statistics

36

Estudios

483763

Participantes

Positive

A

Calificación

Referenced Papers

Journal of ethnopharmacology 2024 6 citas
British journal of … 2006 351 citas
Alternative medicine review … 1998 58 citas
Clinical neuropharmacology 1994 18 citas

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

sleep:
3 g, 1 hour before bed

Límite superior: Not established; studied up to 9 g/day

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
Lactobacillus reuteri E9 (dose not specified) -- Positive --
various homoeopathic remedies (complex homoeopathy, Melissa officinalis 12C, individualised homoeopa -- Positive 451
None -- Neutral --
Arachis hypogaea L. stems and leaves extract -- Positive --
15 g/day collagen peptides (glycine-rich) consumed 1 hour before bedtime for 7 nights 1 weeks Positive 13
None 3 weeks Positive --
not applicable -- Neutral 17
None -- Mixed 482730

Mejor momento para tomar: 1 hour before bed

Safety & Side Effects

Efectos secundarios reportados

  • Nausea
  • Soft stools
  • Mild drowsiness

Interacciones conocidas

  • Clozapine — glycine may reduce effectiveness of this antipsychotic
  • Antihypertensives — potential additive blood pressure lowering

Ingesta máxima tolerable: Not established; studied up to 9 g/day

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Glycine help with Insomnio?
Based on 36 studies with 483,763 participants, there is strong evidence from multiple clinical trials that Glycine may support Insomnio management. Our evidence grade is A (Strong Evidence).
How much Glycine should I take for Insomnio?
Studies have used various dosages. A commonly studied range is 3 g, 1 hour before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Glycine?
Reported side effects may include Nausea, Soft stools, Mild drowsiness. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Glycine and Insomnio?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 36 peer-reviewed studies with 483,763 total participants. The overall direction of effect is positive.

References

  1. [1] Meijia Li et al.. Pharmaceuticals (Basel). 2026. Synergistic Therapeutic Effects of Tetrahydroberberine Combined with Protopanaxadiol on PCPA-Induced Insomnia in Rats: Involvement of the Microbiota-Gut-Brain Axis and Regulation … doi:10.3390/ph19030390 PubMed
  2. [2] Xiaohan Zhang et al.. J Chem Inf Model. 2025. The Glycine-Rich Region as a Flexible Molecular Glue Promoting hPrP106-145 Aggregation into β-Sheet Structures. doi:10.1021/acs.jcim.5c00785 PubMed
  3. [3] Kanchan Upreti et al.. Children (Basel). 2025. Effectiveness of Homoeopathic Treatments for Sleep Disorders in Children and Adolescents: A Systematic Review According to the Principles of Evidence-Based … doi:10.3390/children13010045 PubMed
  4. [4] Yongcheng Jiang et al.. Front Biosci (Landmark Ed). 2025. Lactobacillus reuteri E9 Regulates Sleep Disorders Through Its Metabolite GABA. doi:10.31083/FBL39587 PubMed
  5. [5] Yin Wang et al.. J Pharm Anal. 2025. Time-specific study on the efficacy of stems and leaves of Arachis hypogaea L. targeting glycine/serine metabolism for insomnia treatment. doi:10.1016/j.jpha.2025.101288 PubMed
  6. [6] Craig Thomas et al.. Eur J Nutr. 2024. Collagen peptide supplementation before bedtime reduces sleep fragmentation and improves cognitive function in physically active males with sleep complaints. doi:10.1007/s00394-023-03267-w PubMed
  7. [7] Shujun Wang et al.. J Ethnopharmacol. 2024. Effects of BXSMD on ESR1 and ESR2 expression in CSD female mice. doi:10.1016/j.jep.2023.116973 PubMed
  8. [8] Mengya Chen et al.. Hum Genet. 2023. Investigating the shared genetic architecture and causal relationship between pain and neuropsychiatric disorders. doi:10.1007/s00439-022-02507-z PubMed
  9. [9] Irem Erkent et al.. Neurol Sci. 2023. Sleep disorders and polysomnography findings in patients with autoimmune encephalitis. doi:10.1007/s10072-022-06513-x PubMed
  10. [10] Minsook Ye et al.. Int J Mol Sci. 2023. Sedative-Hypnotic Effects of Glycine max Merr. Extract and Its Active Ingredient Genistein on Electric-Shock-Induced Sleep Disturbances in Rats. doi:10.3390/ijms24087043 PubMed
  11. [11] Samaneh Takhti et al.. J Biomol Struct Dyn. 2023. New hybrids based on benzimidazole and diazepine moieties: design, synthesis, characterization, molecular docking studies and their in vitro interactions with … doi:10.1080/07391102.2022.2136246 PubMed
  12. [12] Yan-Pei Hou et al.. J Formos Med Assoc. 2022. Roxadustat treatment for anemia in peritoneal dialysis patients: A randomized controlled trial. doi:10.1016/j.jfma.2021.06.004 PubMed
  13. [13] Dominique Endres et al.. Brain Sci. 2020. Parkinsonian Syndrome with Frontal Lobe Involvement and Anti-Glycine Receptor Antibodies. doi:10.3390/brainsci10060399 PubMed
  14. [14] Ying Wang et al.. Biomed Res Int. 2019. Metabonomics Study of Ginseng Glycoproteins on Improving Sleep Quality in Mice. doi:10.1155/2019/2561828 PubMed
  15. [15] Jorge J Castillo et al.. Clin Cancer Res. 2018. Prospective Clinical Trial of Ixazomib, Dexamethasone, and Rituximab as Primary Therapy in Waldenström Macroglobulinemia. doi:10.1158/1078-0432.CCR-18-0152 PubMed
  16. [16] Shyamala C Navada et al.. Leuk Res. 2018. A phase 1/2 study of rigosertib in patients with myelodysplastic syndromes (MDS) and MDS progressed to acute myeloid leukemia. doi:10.1016/j.leukres.2017.11.006 PubMed
  17. [17] Rahele Kargozar et al.. Electron Physician. 2017. A review of effective herbal medicines in controlling menopausal symptoms. doi:10.19082/5826 PubMed
  18. [18] Pierre-Hervé Luppi et al.. Sleep Med Rev. 2017. Not a single but multiple populations of GABAergic neurons control sleep. doi:10.1016/j.smrv.2016.03.002 PubMed
  19. [19] Yoshio Hirayasu et al.. BMC Psychiatry. 2016. A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese … doi:10.1186/s12888-016-0778-9 PubMed
  20. [20] Matteo Caloro et al.. Addict Behav. 2016. Use of benzylglycinamide by a HIV-seropositive polysubstance user: The changing pattern of novel psychoactive substance use among youths. doi:10.1016/j.addbeh.2016.03.032 PubMed
  21. [21] Li-Na Chen et al.. Mol Neurobiol. 2016. Proteomic Analyses for the Global S-Nitrosylated Proteins in the Brain Tissues of Different Human Prion Diseases. doi:10.1007/s12035-015-9440-7 PubMed
  22. [22] Jing-Yang Zhang et al.. Fitoterapia. 2015. Gelsemium analgesia and the spinal glycine receptor/allopregnanolone pathway. doi:10.1016/j.fitote.2014.11.002 PubMed
  23. [23] Jiapu Zhang et al.. Acta Biochim Biophys Sin (Shanghai). 2013. Molecular dynamics studies on 3D structures of the hydrophobic region PrP(109-136). doi:10.1093/abbs/gmt031 PubMed
  24. [24] Makoto Bannai et al.. Front Neurol. 2012. The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. doi:10.3389/fneur.2012.00061 PubMed
  25. [25] Makoto Bannai et al.. Psychiatry Clin Neurosci. 2011. Oral administration of glycine increases extracellular serotonin but not dopamine in the prefrontal cortex of rats. doi:10.1111/j.1440-1819.2010.02181.x PubMed
  26. [26] Vera M Kalscheuer et al.. Hum Mutat. 2009. A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation. doi:10.1002/humu.20814 PubMed
  27. [27] David J Morris et al.. Steroids. 2009. Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues revisited. doi:10.1016/j.steroids.2008.10.005 PubMed
  28. [28] Rajdeep Dasgupta et al.. Curr Drug Deliv. 2009. Investigation of in vitro iontophoresis facilitated transdermal delivery of glycine. doi:10.2174/156720109787846207 PubMed
  29. [29] Atsushi Takeda et al.. Nutr Neurosci. 2008. Suppressive effect of Yokukansan on excessive release of glutamate and aspartate in the hippocampus of zinc-deficient rats. doi:10.1179/147683008X301414 PubMed
  30. [30] Jing Ye et al.. J Med Case Rep. 2008. Human prion disease with a G114V mutation and epidemiological studies in a Chinese family: a case series. doi:10.1186/1752-1947-2-331 PubMed
  31. [31] N G Bowery et al.. Br J Pharmacol. 2006. GABA and glycine as neurotransmitters: a brief history. doi:10.1038/sj.bjp.0706443 PubMed
  32. [32] M Mucci et al.. Minerva Ginecol. 2006. Soy isoflavones, lactobacilli, Magnolia bark extract, vitamin D3 and calcium. Controlled clinical study in menopause. PubMed
  33. [33] Béatrice Astruc et al.. Br J Clin Pharmacol. 2005. Steady-state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects. doi:10.1111/j.1365-2125.2005.02338.x PubMed
  34. [34] Ana Lia Taratuto et al.. Neurology. 2002. Insomnia associated with thalamic involvement in E200K Creutzfeldt-Jakob disease. doi:10.1212/wnl.58.3.362 PubMed
  35. [35] G S Kelly. Altern Med Rev. 1998. Folates: supplemental forms and therapeutic applications. PubMed
  36. [36] D E Burdette et al.. Clin Neuropharmacol. 1994. Felbamate pharmacology and use in epilepsy. doi:10.1097/00002826-199410000-00001 PubMed
  37. [37] T Dyckner et al.. Eur J Clin Pharmacol. 1986. Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial … doi:10.1007/BF00542411 PubMed

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.